Chapter 4.5 The endocannabinoid system and anxiety responses

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · see citing works

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389 · see citing works

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · see citing works

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196 · see citing works

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · see citing works

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125 · see citing works

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · see citing works

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,751 · see citing works

The endogenous cannabinoid system controls extinction of aversive memories

Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · see citing works

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607 · see citing works

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585 · see citing works

Mechanisms of emotional arousal and lasting declarative memory.

Cahill, L., & McGaugh, J. L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01214-9 · Cited by 1,575 · see citing works

Role of Endogenous Cannabinoids in Synaptic Signaling

Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,567 · see citing works

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Gaal, L. F. V., Rissanen, A., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,500 · see citing works

A second endogenous cannabinoid that modulates long-term potentiation

Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399 · see citing works

Brain monoglyceride lipase participating in endocannabinoid inactivation

Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · see citing works

Modulation of anxiety through blockade of anandamide hydrolysis

Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · see citing works

Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients

Pi-Sunyer, X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & for the RIO-North America Study Group (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,209 · see citing works

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052 · see citing works

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039 · see citing works

Neuroscience of addiction

Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026 · see citing works

Cannabis use and mental health in young people: cohort study.

Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002) · BMJ · doi:10.1136/bmj.325.7374.1195 · Cited by 997 · see citing works

The neurobiology and control of anxious states

Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 963 · see citing works

Emotion, Memory and the Brain

LeDoux, J. E. (1994) · Scientific American · doi:10.1038/scientificamerican0694-50 · Cited by 892 · see citing works

Endogenous Cannabinoids Mediate Retrograde Signals from Depolarized Postsynaptic Neurons to Presynaptic Terminals

Ohno‐Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 846 · see citing works

Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala

Miserendino, M. J. D., Sananes, C. B., Melia, K. R., & Davis, M. (1990) · Nature · doi:10.1038/345716a0 · Cited by 824 · see citing works

Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition

Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813 · see citing works

The effects of cannabinoids on the brain

Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 805 · see citing works

Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners

Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 800 · see citing works

An endocannabinoid mechanism for stress-induced analgesia

Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778 · see citing works

Adverse effects of cannabis

Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 778 · see citing works

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

Giuffrida, A., Parsons, L. H., Kerr, T. M., de Fonseca, F. R., Navarro, M. A., & Piomelli, D. (1999) · Nature Neuroscience · doi:10.1038/7268 · Cited by 771 · see citing works

Neurotransmission in the rat amygdala related to fear and anxiety

Davis, M., Rainnie, D., & Cassell, M. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90106-6 · Cited by 771 · see citing works

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

Gerdeman, G. L., Ronesi, J. A., & Lovinger, D. M. (2002) · Nature Neuroscience · doi:10.1038/nn832 · Cited by 767 · see citing works

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H.-U., & van Os, J. (2005) · BMJ · doi:10.1136/bmj.38267.664086.63 · Cited by 765 · see citing works

Distribution of cannabinoid receptors in the central and peripheral nervous system

Mackie, K. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_10 · Cited by 744 · see citing works

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

Gobbi, G., Bambico, F. R., Mangieri, R. A., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M. G., Debonnel, G., Duranti, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509591102 · Cited by 676 · see citing works

Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission

Katona, I., Rancz, E. A., Acsády, L., Ledent, C., Mackie, K., Hájos, N., & Freund, T. F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09506.2001 · Cited by 668 · see citing works

Neocortical LTD via Coincident Activation of Presynaptic NMDA and Cannabinoid Receptors

Sjöström, P. J., Turrigiano, G. G., & Nelson, S. B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00476-8 · Cited by 610 · see citing works

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. M., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, É., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 598 · see citing works

Cannabis use and psychosocial adjustment in adolescence and young adulthood

Fergusson, D. M., Horwood, L. J., & Swain‐Campbell, N. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00103.x · Cited by 563 · see citing works

Preclinical models: status of basic research in depression

Nestler, E. J., Gould, E., & Manji, H. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01405-1 · Cited by 559 · see citing works

Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain

Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 537 · see citing works

The cannabinoid receptors

Howlett, A. C. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00060-6 · Cited by 536 · see citing works

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat

Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515 · see citing works

Stress and emotionality: a multidimensional and genetic approach

Ramos, A., & Mormède, P. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(97)00001-8 · Cited by 514 · see citing works

Involvement of CB1 cannabinoid receptors in emotional behaviour

Martín, M., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0946-5 · Cited by 507 · see citing works

Health aspects of cannabis

Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500 · see citing works

Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal

Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499 · see citing works

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research

Griebel, G. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)98597-j · Cited by 487 · see citing works

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

Giuffrida, A., Leweke, F. M., Gerth, C. W., Schreiber, D., Koethe, D., Faulhaber, J., Klosterkötter, J., & Piomelli, D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300558 · Cited by 481 · see citing works

Endocannabinoid Signaling Negatively Modulates Stress-Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis

Patel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475 · see citing works

A biosynthetic pathway for anandamide

Liu, J., Wang, L., Harvey-White, J. D., Osei‐Hyiaman, D., Razdan, R. J., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 468 · see citing works

The Environment and Schizophrenia: The Role of Cannabis Use

Henquet, C. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi027 · Cited by 448 · see citing works

Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597)

Piomelli, D., Tarzia, G., Duranti, A., Tontini, A., Mor, M., Compton, T. R., Dasse, O. A., Monaghan, E. P., Parrott, J. A., & Putman, D. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00021.x · Cited by 445 · see citing works

Animal models of ‘anxiety’: Where next?

Rodgers, R. J. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00003 · Cited by 437 · see citing works

Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation

Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078980 · Cited by 427 · see citing works

Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus

Varma, N., Carlson, G. C., Ledent, C. A., & Alger, B. E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-j0003.2001 · Cited by 407 · see citing works

Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor,N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain

Cadas, H., di Tomaso, E., & Piomelli, D. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01226.1997 · Cited by 394 · see citing works

Pharmacological and biochemical interactions between opioids and cannabinoids

Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 391 · see citing works

Being stoned: a review of self‐reported cannabis effects

Green, B., Kavanagh, D. J., & Young, R. M. (2003) · Drug and Alcohol Review · doi:10.1080/09595230310001613976 · Cited by 390 · see citing works

Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling

Patel, S., & Hillard, C. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101287 · Cited by 390 · see citing works

Evidence for novel cannabinoid receptors

Begg, M., Pacher, P., Bátkai, S., Osei‐Hyiaman, D., Offertáler, L., Mo, F.-M., LIU, J., & Kunos, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.005 · Cited by 385 · see citing works

Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear

Chhatwal, J. P., Davis, M., Maguschak, K. A., & Ressler, K. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300655 · Cited by 376 · see citing works

Experimental Approaches to Anxiety and Depression

Elliott, J. M., Heal, D. J., & Mardens, C. A. (1993) · Behavioural Pharmacology · doi:10.1097/00008877-199310000-00012 · Cited by 363 · see citing works

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety

Haller, J., Bakos, N., Szirmay, M., Ledent, C., & Freund, T. F. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02192.x · Cited by 354 · see citing works

Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress

Bortolato, M., Mangieri, R. A., Fu, J., Kim, J. H., Arguello, O., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.001 · Cited by 347 · see citing works

Accumulation of N‐Arachidonoylethanolamine (Anandamide) into Cerebellar Granule Cells Occurs via Facilitated Diffusion

Hillard, C. J., Edgemond, W. S., Jarrahian, A., & Campbell, W. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020631.x · Cited by 337 · see citing works

Anandamide Amidohydrolase Activity in Rat Brain Microsomes

Desarnaud, F., Cadas, H., & Piomelli, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6030 · Cited by 336 · see citing works

Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity

Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069401 · Cited by 329 · see citing works

Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine

Valjent, E., Mitchell, J., Besson, M., Caboche, J., & Maldonado, R. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704479 · Cited by 321 · see citing works

Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior

Shepard, J. D., Barron, K. W., & Myers, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02019-9 · Cited by 321 · see citing works

A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation

Dinh, T. P., Freund, T. F., & Piomelli, D. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00150-0 · Cited by 319 · see citing works

Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1

Marsicano, G., Moosmann, B., Hermann, H., Lutz, B., & Behl, C. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00716.x · Cited by 313 · see citing works

Pharmacological characterization of cannabinoids in the elevated plus maze.

Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 312 · see citing works

Behavioral Effects of Cannabinoid Agents in Animals

Chaperon, F., & Thiébot, M.-H. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i3.20 · Cited by 311 · see citing works

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat

Navarro, M., Hernández, E., Muñoz, R. M., del Arco, I., Villanúa, M. Á., Carrera, M. R. A., & de Fonseca, F. R. (1997) · Neuroreport · doi:10.1097/00001756-199701200-00023 · Cited by 306 · see citing works

Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide

Ueda, N., Kurahashi, Y., Yamamoto, S., & Tokunaga, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23823 · Cited by 303 · see citing works

Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia

Lichtman, A. H., Shelton, C. C., Advani, T., & Cravatt, B. F. (2004) · Pain · doi:10.1016/j.pain.2004.01.022 · Cited by 301 · see citing works

Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling

Patel, S., Roelke, C. T., Rademacher, D. J., & Hillard, C. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03916.x · Cited by 297 · see citing works

Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats

O’Shea, M., Singh, M. E., McGregor, I. S., & Mallet, P. E. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047277 · Cited by 292 · see citing works

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

Jayamanne, A., Greenwood, R., Mitchell, V. A., Aslan, S., Piomelli, D., & Vaughan, C. W. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706510 · Cited by 287 · see citing works

Structural determinants for recognition and translocation by the anandamide transporter

Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S., Goutopoulos, A., Xie, X., & Makriyannis, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5802 · Cited by 268 · see citing works

Therapeutic aspects of cannabis and cannabinoids

Robson, P. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.2.107 · Cited by 265 · see citing works

Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors

Ghozland, S. G., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263 · see citing works

The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders

Nemeroff, C. B., MD, & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4169 · Cited by 263 · see citing works

A Functional Neuroanatomy of Anxiety and Fear: Implications for the Pathophysiology and Treatment of Anxiety Disorders

Deutch, A. Y., & Charney, D. S. (1996) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v10.i3-4.70 · Cited by 260 · see citing works

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

Griebel, G., Stemmelin, J., & Scatton, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.032 · Cited by 253 · see citing works

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors

Gatley, S. J., Gifford, A. N., Volkow, N. D., Lan, R., & Makriyannis, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00279-8 · Cited by 252 · see citing works

CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

Haller, J., Varga, B., Ledent, C., & Freund, T. F. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000135704.56422.40 · Cited by 241 · see citing works

Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus

Kim, J., & Alger, B. E. (2004) · Nature Neuroscience · doi:10.1038/nn1262 · Cited by 238 · see citing works

Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D

Yong-Xin, S. U. N., Tsuboi, K., Okamoto, Y., Tonai, T., Murakami, M., Kudo, I., & Ueda, N. (2004) · Biochemical Journal · doi:10.1042/bj20040031 · Cited by 236 · see citing works

Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain

Hillard, C. J., Wilkison, D. M., Edgemond, W. S., & Campbell, W. B. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00087-s · Cited by 233 · see citing works

Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404

Bortolato, M., Campolongo, P., Mangieri, R. A., Scattoni, M. L., Frau, R., Trezza, V., Rana, G. L., Russo, R., Calignano, A., Gessa, G. L., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301061 · Cited by 233 · see citing works

Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus

Makara, J. K., Mor, M., Fegley, D., Szabó, S. I., Kathuria, S., Astarita, G., Duranti, A., Tontini, A., Tarzia, G., Rivara, S., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1521 · Cited by 231 · see citing works

Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats

O’Shea, M., McGregor, I. S., & Mallet, P. E. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106065188 · Cited by 230 · see citing works

Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol

Berrendero, F., & Maldonado, R. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1144-9 · Cited by 221 · see citing works

Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors

Urigüen, L., Pérez-Rial, S., Ledent, C., Palomo, T., & Manzanares, J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.003 · Cited by 218 · see citing works

Transmitter systems involved in neural plasticity undelying increased anxiety and defense— Implications for understanding anxiety following traumatic stress

Adamec, R. E. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00055-3 · Cited by 216 · see citing works

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents

Perrault, G., Griebel, G., & Sanger, D. J. (1998) · Psychopharmacology · doi:10.1007/s002130050645 · Cited by 210 · see citing works

Mental health of teenagers who use cannabis

Rey, J. M., SAWYER, M. G., Raphael, B., Patton, G. C., & Lynskey, M. T. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.3.216 · Cited by 207 · see citing works

Experience of non‐fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions

McGregor, C. A., Darke, S. G., Ali, R. L., & Christie, P. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9357016.x · Cited by 205 · see citing works

5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze

Gonzalez, L. E., Andrews, N., & File, S. E. (1996) · Brain Research · doi:10.1016/0006-8993(96)00517-3 · Cited by 204 · see citing works

Cellular accumulation of anandamide: consensus and controversy

Hillard, C. J., & Jarrahian, A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705468 · Cited by 199 · see citing works

Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers

Hájos, N., & Freund, T. F. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00157-0 · Cited by 198 · see citing works

Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors

Jung, K., Mangieri, R. A., Stapleton, C. J., Kim, J., Fegley, D., Wallace, M., Mackie, K., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013961 · Cited by 197 · see citing works

Experimental approaches to anxiety and depression

McCall, W. V. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90335-v · Cited by 186 · see citing works

Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.

Menzaghi, F., Howard, R. L., Heinrichs, S. C., Vale, W., Rivier, J., & Koob, G. F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38740-9 · Cited by 181 · see citing works

Effect of the Brain Constituent Anandamide, a Cannabinoid Receptor Agonist, on the Hypothalamo-Pituitary-Adrenal Axis in the Rat

Weidenfeld, J., Feldman, S., & Mechoulam, R. (2008) · Neuroendocrinology · doi:10.1159/000126646 · Cited by 179 · see citing works

Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters

Arévalo, C., de Miguel, R., & Hernández‐Tristán, R. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00578-0 · Cited by 175 · see citing works

Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.

de Fonseca, F. R., Rubio, P., Menzaghi, F., Merlo‐Pich, E., Rivier, J., Koob, G. F., & Navarro, M. A. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12276-3 · Cited by 175 · see citing works

Inhibition of Fatty-Acid Amide Hydrolase Accelerates Acquisition and Extinction Rates in a Spatial Memory Task

Varvel, S. A., Wise, L. E., Niyuhire, F., Cravatt, B. F., & Lichtman, A. H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301224 · Cited by 173 · see citing works

Δ9‐tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

Valverde, O., Noble, F., Beslot, F., Daugé, V., Fournié‐Zaluski, M., & Roques, B. P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01558.x · Cited by 172 · see citing works

Is There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders?

Griebel, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00041-2 · Cited by 171 · see citing works

Oxidative metabolism of endocannabinoids

Kozak, K. R., & Marnett, L. J. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0359 · Cited by 170 · see citing works

Synergistic interactions of endogenous opioids and cannabinoid systems

Welch, S. P., & Eads, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01908-3 · Cited by 169 · see citing works

Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors

Holt, S., Comelli, F., Costa, B., & Fowler, C. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706348 · Cited by 168 · see citing works

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Chang, L., Luo, L., Palmer, J. A., Sutton, S. W., Wilson, S. J., Barbier, A., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706773 · Cited by 166 · see citing works

Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala

Patel, S., Cravatt, B. F., & Hillard, C. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300535 · Cited by 164 · see citing works

Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes

Saario, S. M., Savinainen, J. R., Laitinen, J. T., Järvinen, T., & Niemi, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.003 · Cited by 163 · see citing works

The expanding field of cannabimimetic and related lipid mediators

Bradshaw, H. B., & Walker, J. M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706093 · Cited by 161 · see citing works

Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain

Jhaveri, M. D., Richardson, D., Kendall, D. A., Barrett, D. A., & Chapman, V. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3326-06.2006 · Cited by 159 · see citing works

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Chang, L., Luo, L., Palmer, J. A., Sutton, S., Wilson, S. J., Barbier, A. J., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706699 · Cited by 155 · see citing works

The endocannabinoid system: a drug discovery perspective.

Piomelli, D. (2005) · PubMed · Cited by 152 · see citing works

Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus

Schlicker, E., Timm, J., Zentner, J., & Göthert, M. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005093 · Cited by 144 · see citing works

The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being

Degenhardt, L. J., Hall, W., & Lynskey, M. T. (2001) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270170052 · Cited by 143 · see citing works

Effects of intra-amygdala injections of NMDA receptor antagonists on acquisition and retention of inhibitory avoidance

Kim, M., & McGaugh, J. L. (1992) · Brain Research · doi:10.1016/0006-8993(92)91188-k · Cited by 143 · see citing works

Absence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice

Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H., Valverde, O., & Maldonado, R. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09499.2001 · Cited by 140 · see citing works

Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors

Gatley, S. J., Lan, R., Pyatt, B. E., Gifford, A. N., Volkow, N. D., & Makriyannis, A. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00690-5 · Cited by 140 · see citing works

The Efficacy and Safety of Nabilone (A Synthetic Cannabinoid) in the Treatment of Anxiety

FABRE, L. F., & McLENDON, D. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02617.x · Cited by 138 · see citing works

Oxidative Metabolism of Endocannabinoids by COX-2

Kozak, K. R., Prusakiewicz, J. J., & Marnett, L. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453081 · Cited by 136 · see citing works

Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats

Marco, E. M., rez-Alvarez, L. P., Borcel, É., Rubio, M., Guaza, C., Ambrosio, E., File, S. E., & Viveros, M. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200402000-00003 · Cited by 133 · see citing works

Synaptic transmission and plasticity in the amygdala

Maren, S. (1996) · Molecular Neurobiology · doi:10.1007/bf02740749 · Cited by 132 · see citing works

THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.

Parker, L. A., & Gillies, T. (1995) · Behavioral Neuroscience · doi:10.1037//0735-7044.109.1.71 · Cited by 128 · see citing works

The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze

Takahashi, R. N., Pamplona, F. A., & Fernandes, M. S. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.049 · Cited by 127 · see citing works

Survey of Australians using cannabis for medical purposes

Swift, W., Gates, P., & Dillon, P. (2005) · Harm Reduction Journal · doi:10.1186/1477-7517-2-18 · Cited by 126 · see citing works

Role of P/Q-Ca2+ Channels in Metabotropic Glutamate Receptor 2/3-Dependent Presynaptic Long-Term Depression at Nucleus Accumbens Synapses

Robbe, D., Alonso, G., Chaumont‐Dubel, S., Bockaert, J., & Manzoni, O. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04346.2002 · Cited by 124 · see citing works

Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test

Heilig, M. A., McLeod, S., Koob, G. K., & Britton, K. T. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90514-u · Cited by 123 · see citing works

Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation

Maccarrone, M., Bari, M., Battista, N., & Finazzi‐Agrò, A. (2002) · Blood · doi:10.1182/blood-2002-05-1444 · Cited by 122 · see citing works

Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.

Fadda, P., Robinson, L., Fratta, W., Pertwee, R., & Riedel, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.009 · Cited by 122 · see citing works

THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.

Parker, L. A., & Gillies, T. (1995) · Behavioral Neuroscience · doi:10.1037/0735-7044.109.1.71 · Cited by 122 · see citing works

5-HT1A receptors are involved in the anxiolytic effect of Δ9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague–Dawley rats

Braida, D., Limonta, V., Malabarba, L., Zani, A. D., & Sala, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.038 · Cited by 115 · see citing works

Enhancement of anxiety-like responsiveness to the cannabinoid CB1 receptor agonist HU-210 following chronic stress

Hill, M. N., & Gorzalka, B. B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.069 · Cited by 114 · see citing works

Cholecystokinin in anxiety

van Megen, H. J. G. M., Westenberg, H. G. M., den Boer, J. A., & Kahn, R. (1996) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00038-7 · Cited by 113 · see citing works

The marijuana withdrawal syndrome: Diagnosis and treatment

Haney, M. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0036-1 · Cited by 112 · see citing works

Reduction of stress‐induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

Valverde, O., Ledent, C. A., Beslot, F., Parmentier, M., & Roques, B. P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00929.x · Cited by 111 · see citing works

Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum

Herkenham, M. A., Groen, B. G. S., Lynn, A. B., Costa, B., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90096-e · Cited by 111 · see citing works

The Role of Corticotropin‐Releasing Factor in the Anxiogenic Effects of Ethanol Withdrawal

Menzaghi, F., Rassnick, S., Heinrichs, S. C., Baldwin, H. A., Pich, E. M., Weiss, F., & Koob, G. F. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb19819.x · Cited by 109 · see citing works

The relationship between cannabis use and DSM-IV cannabis abuse and dependence: results from the national longitudinal alcohol epidemiologic survey

Grant, B. F., & Pickering, R. P. (1998) · Journal of Substance Abuse · doi:10.1016/s0899-3289(99)00006-1 · Cited by 108 · see citing works

Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry.

Stein, D. J., Westenberg, H. G. M., & Liebowitz, M. R. (2002) · PubMed · Cited by 103 · see citing works

Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-na??ve and plus-maze-experienced mice

Rodgers, R. J., Evans, P., & Murphy, A. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00013 · Cited by 98 · see citing works

Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminobutyric acidA receptor blockade in the basolateral amygdala of rats.

Sajdyk, T. J., & Shekhar, A. (1997) · PubMed · Cited by 96 · see citing works

The evidence for the existence of cannabinoid receptors

Pertwee, R. G. (1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90154-p · Cited by 95 · see citing works

Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test

Genn, R. F., Tucci, S. A., Marco, E. M., Viveros, M., & File, S. E. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.12.019 · Cited by 92 · see citing works

Possible involvement of the endocannabinoid system in the actions of three clinically used drugs

Fowler, C. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.12.001 · Cited by 91 · see citing works

‘One‐trial sensitization’ to the anxiolytic‐like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus‐maze

Rodgers, R. J., Haller, J., Halász, J., & Mikics, É. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02548.x · Cited by 88 · see citing works

Co‐twin control study of relationships among combat exposure, combat‐related PTSD, and other mental disorders

Koenen, K. C., Lyons, M. J., Goldberg, J., Simpson, J., Williams, W. M., Toomey, R., Eisen, S. A., True, W., & Tsuang, M. T. (2003) · Journal of Traumatic Stress · doi:10.1023/a:1025786925483 · Cited by 88 · see citing works

Variability in subjective responses to cocaine: initial experiences of college students

Davidson, E. S., Finch, J. F., & Schenk, S. (1993) · Addictive Behaviors · doi:10.1016/0306-4603(93)90062-e · Cited by 86 · see citing works

Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids

Beinfeld, M. C., & Connolly, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01591-9 · Cited by 86 · see citing works

Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents

Hopfer, C. J., Young, S. E., Purcell, S., Crowley, T. J., Stallings, M. C., Corley, R. P., Rhee, S. H., Smolen, A., Krauter, K., Hewitt, J. K., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30378 · Cited by 82 · see citing works

Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries

O’Sullivan, S. E., Kendall, D. A., & Randall, M. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705810 · Cited by 81 · see citing works

Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats

Romero, E., Martín‐Fernández, B., Sagredo, O., Gomez, N., Urigüen, L., Guaza, C., de Miguel, R., Ramos, J. A., & Viveros, M. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00306-1 · Cited by 81 · see citing works

Metabotropic glutamate receptor 2/3‐dependent long‐term depression in the nucleus accumbens is blocked in morphine withdrawn mice

Robbe, D., Bockaert, J., & Manzoni, O. J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02273.x · Cited by 81 · see citing works

Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats

Marı́n, S., Marco, E. M., Biscaia, M., Fernández, B., Rubio, M., Guaza, C., Schmidhammer, H., & Viveros, M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01041-9 · Cited by 78 · see citing works

Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers.

Zuardi, A. W., Guimarães, F. S., & Moreira, A. C. (1993) · PubMed · Cited by 76 · see citing works

Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats

Deiana, S., Fattore, L., Spano, M. S., Cossu, G., Porcu, E., Fadda, P., & Fratta, W. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.007 · Cited by 74 · see citing works

Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users

Milani, R. M., Parrott, A. C., Turner, J. J., & Fox, H. C. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.02.044 · Cited by 73 · see citing works

Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2

Schneider, M., Drews, E., & Koch, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00018 · Cited by 72 · see citing works

THE CANNABINOID AGONIST HU 210 MODIFIES RAT BEHAVIOURAL RESPONSES TO NOVELTY AND STRESS

Giuliani, D., FERRARI, F., & Ottani, A. (2000) · Pharmacological Research · doi:10.1006/phrs.1999.0560 · Cited by 67 · see citing works

Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats

Marco, E. M., Granstrem, O., Moreno, E., Llorente, R., Adriani, W., Giovanni Laviola, A., & Viveros, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.013 · Cited by 67 · see citing works

In-Vitro and In-Vivo Action of Cannabinoids

Akinshola, B. E., Chakrabarti, A., & Onaivi, E. S. (1999) · Neurochemical Research · doi:10.1023/a:1020968922151 · Cited by 66 · see citing works

Comorbid cannabis use and panic disorder: short term and long term follow‐up study

Dannon, P. N., Lowengrub, K., Amiaz, R., Grunhaus, L. J., & Kotler, M. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.560 · Cited by 66 · see citing works

Effects of cannabinoids on the anxiety-like response in mice.

Rutkowska, M., Jamontt, J., & Gliniak, H. (2006) · PubMed · Cited by 66 · see citing works

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide

de Lago, E., Fernández‐Ruíz, J., Ortega‐Gutiérrez, S., Viso, A., López-Rodríguez, M. L., & Ramos, J. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01996-9 · Cited by 65 · see citing works

Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors

Gelfand, E. V., & Cannon, C. P. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.3.307 · Cited by 63 · see citing works

The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze

Chopin, P., & Briley, M. (1993) · Psychopharmacology · doi:10.1007/bf02244646 · Cited by 62 · see citing works

The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice

Mikics, É., Dombi, T., Barsvári, B., Varga, B., Ledent, C., Freund, T., & Haller, J. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200605000-00003 · Cited by 61 · see citing works

Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (“Ecstasy”) in rats

Morley, K. C., Li, K. M., Hunt, G. E., Mallet, P. E., & McGregor, I. S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.002 · Cited by 59 · see citing works

Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock‐probe burying test

Degroot, A., & Nomikos, G. G. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03556.x · Cited by 58 · see citing works

Excitatory Amino Acid Receptor Antagonists Block the Cardiovascular and Anxiety Responses Elicited by γ-Aminobutyric AcidA Receptor Blockade in the Basolateral Amygdala of Rats

Sajdyk, T. J., & Shekhar, A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37060-0 · Cited by 57 · see citing works

Mouse strain differences in the behavioral effects of Corticotropin-Releasing Factor (CRF) and the CRF antagonist α-helical CRF9–41

Conti, L. H., Costello, D. G., Martin, L. A., White, M. F., & Abreu, M. E. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90559-2 · Cited by 49 · see citing works

Endocannabinoids, hormone-cytokine networks and human fertility

Maccarrone, M., Falciglia, K., Rienzo, M. D., & Finazzi‐Agrò, A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0354 · Cited by 48 · see citing works

Rodent models of anxiety-like behaviors: are they predictive for compounds acting via non-benzodiazepine mechanisms?

Belzung, C. (2001) · PubMed · Cited by 45 · see citing works

The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze

Bickerdike, M. J., Marsden, C. A., Dourish, C. T., & Fletcher, A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90800-1 · Cited by 43 · see citing works

Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence

Célèrier, E., Ahdepil, T., Wikander, H., Berrendero, F., Nyberg, F., & Maldonado, R. J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.017 · Cited by 43 · see citing works

Post-traumatic stress disoder, survivor guilt and substance use - a study of hospitalised Nigerian army veterans

Okulate, G. T., & Jones, O. B. (2006) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v12i1.53 · Cited by 41 · see citing works

Involvement of hypothalamic corticotropin-releasing factor neurons in behavioral responses to novelty in rats

Menzaghi, F., Heinrichs, S. C., Merlo‐Pich, E., Tilders, F. J. H., & Koob, G. F. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90435-9 · Cited by 37 · see citing works

Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs

Dawson, G. R., Rupniak, N. M. J., Iversen, S. D., Curnow, R., Tye, S. J., Stanhope, K. J., & Tricklebank, M. D. (1995) · Psychopharmacology · doi:10.1007/bf02245597 · Cited by 35 · see citing works

Tetrahydrocannabinol Homologs with Marihuana Activity. IX1

ADAMS, R. L. P., Loewe, S., Jelinek, C., & Wolff, H. (1941) · Journal of the American Chemical Society · doi:10.1021/ja01852a052 · Cited by 35 · see citing works

Evidence for Endogenous Excitatory Amino Acids as Mediators in DSI of GABAAergic Transmission in Hippocampal CA1

Morishita, W., & Alger, B. E. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.5.2556 · Cited by 33 · see citing works

Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats

Charrier, D., Dangoumau, L., Puech, A. J., Hamon, M., & Thiébot, M.-H. (1995) · Psychopharmacology · doi:10.1007/bf02245599 · Cited by 28 · see citing works

Telencephalic but not diencephalic noradrenaline depletion enhances behavioural but not endocrine measures of fear conditioning to contextual stimuli.

Selden, N., Everitt, B., & Robbins, T. W. (1991) · Behavioural Brain Research · doi:10.1016/s0166-4328(05)80064-6 · Cited by 28 · see citing works

Cannabinoid Receptors: Which Cells, Where, How, and Why?

Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1992) · PsycEXTRA Dataset · doi:10.1037/e496112006-007 · Cited by 28 · see citing works

50 years of hurdles and hope in anxiolytic drug discovery

Griebel, G., & Holmes, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4075 · Cited by 414 · see citing works

Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment

Wei, D., Dinh, D., Lee, D., Li, D., Anguren, A., Moreno-Sanz, G., Gall, C. M., & Piomelli, D. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0008 · Cited by 122 · see citing works

Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives

Tambaro, S., & Bortolato, M. (2011) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912798842269 · Cited by 89 · see citing works

Long-term CB1 receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids

Tambaro, S., Tomasi, M. L., & Bortolato, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.009 · Cited by 33 · see citing works

Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis

Bortolato, M., Bini, V., & Tambaro, S. (2010) · Pharmaceuticals · doi:10.3390/ph3092799 · Cited by 14 · see citing works

Interactions of Cannabis and Amphetamine-Type Stimulants

Tambaro, S., & Bortolato, M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_16 · Cited by 4 · see citing works

Basketbol Hakemlerinin Yeni Tip Koronavirüse (Covid-19) Yakalanma Kaygılarının Araştırılması

Özkan, Z., Kahraman, M. Z., Arslan, E., İLİK, A., HANEDANOĞLU, Y., & Kaplan, Ş. (2022) · Gaziantep Üniversitesi Spor Bilimleri Dergisi · doi:10.31680/gaunjss.1056021 · Cited by 1 · see citing works

Endocannabinoid system and stress and anxiety responses

VIVEROS, M., MARCO, E., & FILE, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.029 · Cited by 485 · see citing works

Participation of the Cannabinoid System in the Regulation of Emotional- Like Behaviour

Valverde, O. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774370780 · Cited by 40 · see citing works

The Endocannabinoid System and Anxiety

Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56 · see citing works

Implications for Emotional Responses

Viveros, M.-P., Marco, E.-M., Llorente, R., & López-gallardo, M. (2013)

The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders

Hill, M. N., & Gorzalka, B. B. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824624 · Cited by 155 · see citing works